Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LYRICA 75 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LYRICA 75 MG CAPSULAS DURAS

Approved

STANDARD

LYRICA 75 MG CAPSULAS DURAS

Upjohn Eesv🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 14, 2022
Approval ID: 7d38e4d0af475906
Company: Upjohn Eesv
Type: Standard

Approval Details

Approval Id: 7d38e4d0af475906
Drug Cima Aemps Name: LYRICA 75 MG CAPSULAS DURAS
Register Number: 04279012IP1
Holder Company Name: Upjohn Eesv
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/upjohn-eesv
Authorization Date: 2022-07-14
Dosage Form: CÁPSULA DURA
Dose: 75 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Upjohn Eesv
Company Detail Path: /organization/upjohn-eesv

Company Information

Pharmaceutical Company Name: Upjohn EESV
Country Name: Netherlands

Active Ingredients

PREGABALINA

75 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 14, 2022

Approval ID

7d38e4d0af475906

Type

Standard

Back to CIMA-AEMPS Approvals